Trends in Survival After Surgery for Breast Cancer Metastatic to the Brain and Spinal Column in Medicare Patients: A Population-Based Analysis

被引:16
作者
Cahill, Kevin S. [1 ]
Chi, John H. [1 ]
Day, Art L. [1 ]
Claus, Elizabeth B. [1 ,2 ]
机构
[1] Harvard Univ, Brigham & Womens Hosp, Dept Neurosurg, Sch Med, Boston, MA 02115 USA
[2] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA
关键词
Breast cancer; Craniotomy; Laminectomy; Postoperative survival; Spinal fusion; NERVOUS-SYSTEM METASTASES; SURGICAL-TREATMENT; PROGNOSTIC-FACTORS; RANDOMIZED-TRIAL; CNS METASTASES; CARCINOMA; TUMORS; TRASTUZUMAB; PREDICTION; RESECTION;
D O I
10.1227/NEU.0b013e31820773b2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND: Central nervous system (CNS) metastases are a common occurrence in patients with breast cancer and are identified in up to 30% of patients at autopsy. OBJECTIVE: To determine population-based estimates of survival times after surgical intervention for Medicare patients with metastatic breast cancer to the brain and spinal column. METHODS: Female breast cancer patients with metastases to the brain and spinal column and undergoing neurosurgical treatment were identified through the Surveillance, Epidemiology, and End Results-Medicare database. Estimates of survival were calculated with Kaplan-Meier estimation and a Cox proportional hazards model. RESULTS: There were 643 patients who underwent neurosurgical treatment of metastatic disease from 1986 to 2005. Of these patients, 264 underwent cranial surgery and 379 underwent spinal surgery. There were 40 deaths during the postoperative hospital admission for an inpatient postoperative death rate of 6.2%. Inpatient death has declined by approximately 50% for surgeries performed in the most recent decade; however, the 30-day mortality rate of 9.0% has remained constant. The median postoperative survival after cranial surgery was 7.8 months (95% confidence interval, 6.2-9.2), after laminectomy was 9.4 months (95% confidence interval, 6.3-15.7), and after spinal fusion was 15.7 months (95% confidence interval, 11.9-18.5). Survival after spinal fusion has increased by approximately 50% in the recent decade. Patients with increased survival after cranial surgery were younger, had fewer comorbidities, and had longer periods from breast cancer diagnosis to surgery. Patients with increased survival after spinal neurosurgery had lower-grade lesions and longer time periods from breast cancer diagnosis to surgical treatment. CONCLUSION: After surgically treated metastases, one-third of cranial patients and one-half of spinal patients are alive at 1 year. The overall postoperative survival has increased over time only for spinal fusion procedures.
引用
收藏
页码:705 / 713
页数:9
相关论文
共 50 条
  • [31] Long-term trends in the incidence of male breast cancer and nomogram for predicting survival in male breast cancer patients: a population-based epidemiologic study
    Huang, Aimin
    Li, Daning
    Fan, Zhe
    Chen, Jingfang
    Zhang, Weidong
    Wu, Wentao
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [32] Population-based outcomes after whole brain radiotherapy and re-irradiation in patients with metastatic breast cancer in the trastuzumab era
    Irene Karam
    Alan Nichol
    Ryan Woods
    Scott Tyldesley
    Radiation Oncology, 6
  • [33] Risk factors and survival prediction of young breast cancer patients with liver metastases: a population-based study
    Pu, Chen-Chen
    Yin, Lei
    Yan, Jian-Ming
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [34] Metastatic patterns and survival outcomes in patients with stage IV colon cancer: A population-based analysis
    Wang, Jiwei
    Li, Song
    Liu, Yanna
    Zhang, Chunquan
    Li, Honglang
    Lai, Bin
    CANCER MEDICINE, 2020, 9 (01): : 361 - 373
  • [35] Radiotherapy and Male Breast Cancer A Population-based Registry Analysis
    Madden, Nicholas A.
    Macdonald, Orlan K.
    Call, Jason A.
    Schomas, David A.
    Lee, Christopher M.
    Patel, Shilpen
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2016, 39 (05): : 458 - 462
  • [36] A nomogram for predicting breast cancer specific survival in elderly patients with breast cancer: a SEER population-based analysis
    Yang, Ruoning
    Wu, Yunhao
    Qi, Yana
    Liu, Weijing
    Huang, Ya
    Zhao, Xin
    Chen, Ruixian
    He, Tao
    Zhong, Xiaorong
    Li, Qintong
    Zhou, Li
    Chen, Jie
    BMC GERIATRICS, 2023, 23 (01)
  • [37] A nomogram for predicting breast cancer specific survival in elderly patients with breast cancer: a SEER population-based analysis
    Ruoning Yang
    Yunhao Wu
    Yana Qi
    Weijing Liu
    Ya Huang
    Xin Zhao
    Ruixian Chen
    Tao He
    Xiaorong Zhong
    Qintong Li
    Li Zhou
    Jie Chen
    BMC Geriatrics, 23
  • [38] Nomogram for predicting survival in patients with mucinous breast cancer undergoing chemotherapy and surgery: a population-based study
    Ting Gao
    Yuyuan Chen
    Ming Li
    Keying Zhu
    Rong Guo
    Yiyin Tang
    Sheng Huang
    Dedian Chen
    European Journal of Medical Research, 28
  • [39] Survival Rate of Breast Cancer Patients In Malaysia: A Population-based Study
    Abdullah, Nor Aini
    Mahiyuddin, Wan Rozita Wan
    Muhammad, Nor Asiah
    Ali, Zainudin Mohamad
    Ibrahim, Lailanor
    Tamim, Nor Saleha Ibrahim
    Mustafa, Amal Nasir
    Kamaluddin, Muhammad Amir
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (08) : 4591 - 4594
  • [40] Nomogram for predicting overall survival in patients with invasive micropapillary carcinoma after breast-conserving surgery: A population-based analysis
    Zhao, Yuting
    Li, Shouyu
    Yan, Lutong
    Yang, Zejian
    Chai, Na
    Qiu, Pei
    Zhang, Jian
    Zhang, Huimin
    He, Jianjun
    Zhou, Can
    FRONTIERS IN SURGERY, 2022, 9